Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

Published:2016-03 Issue:3 Volume:94 Page:612-620
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Warner Andrew,Dahele Max,Hu Bo,Palma David A.,Senan Suresh,Oberije Cary,Tsujino Kayoko,Moreno-Jimenez Marta,Kim Tae Hyun,Marks Lawrence B.,Rengan Ramesh,De Petris Luigi,Ramella Sara,De Ruyck Kim,De Dios Núria Rodriguez,Bradley Jeffrey D.,Rodrigues George^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference19 articles.

1. for the ESMO Guidelines Working Group. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2013

2. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Ramnath;Chest,2013

3. Concurrent chemoradiotherapy in non-small cell lung cancer;O'Rourke;Cochrane Database Syst Rev,2010

4. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

5. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis;Palma;Int J Radiat Oncol Biol Phys,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity;Cancer Treatment Reviews;2024-03

2. Traitement standard des stades III non résécables;Revue des Maladies Respiratoires Actualités;2023-10

3. Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer;Cancer Research and Treatment;2023-07-15

4. Analysis of Risk Factors for Radiation Pneu-monia in Pulmonary Malignancies and Construction of a Predictive Model;Advances in Clinical Medicine;2023

5. The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter retrospective cohort study;Clinical and Translational Radiation Oncology;2022-11